The Human Genome, FDA and Product Liability
Mr. Gibbs describes the risks to innovators associated with FDA regulations. He also points out how developers and marketers of products based on human genome research face such risks both before and after marketing.
Jeffrey N. Gibbs, The Human Genome, FDA and Product Liability, 7 RISK 267 (1996).
This document is currently not available here.